Singapore markets closed

Cardiol Therapeutics Inc. (CT9.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.6320+0.0100 (+0.62%)
As of 08:13AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
78.76
0
Operating expenses
Research development
15,802
18,962
10,870
10,603
Selling general and administrative
15,050
22,374
27,873
10,088
Total operating expenses
30,852
41,336
38,744
20,690
Operating income or loss
-30,852
-41,336
-38,665
-20,690
Interest expense
-
-
-
0
Total other income/expenses net
670.587
9,168
6,921
-27.057
Income before tax
-28,006
-30,931
-31,638
-20,641
Income from continuing operations
-28,006
-30,931
-31,638
-20,641
Net income
-28,006
-30,931
-31,638
-20,641
Net income available to common shareholders
-28,006
-30,931
-31,638
-20,641
Basic EPS
-0.43
-0.49
-0.73
-0.69
Diluted EPS
-0.43
-0.49
-0.73
-0.69
Basic average shares
64,129
62,506
43,223
29,857
Diluted average shares
64,129
62,506
43,223
29,857